Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
This is the third school year of the NCAA’s NIL era, granting student-athletes the right to benefit from their Name, Image, and Likeness.
Annual global revenue generated by music copyrights has grown to $41.5 billion, the Financial Times reported.
From cosmetics to apparel to tech, Western brands are seeing revenues dip in China as consumers navigate a struggling post-pandemic economy.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Shares of Starbucks jumped more than 9% Thursday after the company posted better-than-expected Q4 earnings.
Logistical holdups at ports in Brazil combined with poor sugar crops in other major sugar-producing nations is stretching supply of the crop.
The Guardian submitted a complaint to Microsoft on Tuesday after a grotesquely inappropriate AI-generated poll next to a Guardian article.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
While the price of aluminum has climbed off the mat in recent months, it’s still well below the heady days of early 2022.
Salmon fishers in Alaska face a cascade of challenges as state regulators implement a series of restrictions to prevent overfishing.
The U.S. Securities and Exchange Commission announced that it charged BlackRock – the largest money manager in the world, with nearly $10 trillion in…
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.